Global Health Innovation Technology Fund: As the GHIT Fund Closes Out First Five Years of R&D for Lifesaving Medical Breakthroughs, It Launches Next Phase, Focusing on Access and Delivery, Bringing Total Investment to 13.2 Billion Yen (U.S.$123 Million)
“The Global Health Innovative Technology (GHIT) Fund today announced a total of 1.6 billion yen (U.S.$15.5 million) and 10 partnerships to support product development of new lifesaving drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases such as Chagas disease, schistosomiasis, and leishmaniasis…” (3/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.